Guggenheim says this little-known cancer stock can more than double from here
- Posted on October 8, 2025
- By CNBC
- 1 Views
Guggenheim says this little-known cancer stock can more than double from here
Guggenheim applauded CC Oncology's immunotherapy development and "potentially attractive catalyst path."
